(Q72520182)
Statements
Phase I clinical trial of gemcitabine given as an intravenous bolus on 5 consecutive days (English)
T J O'Rourke
T D Brown
K Havlin
J G Kuhn
J B Craig
H A Burris
W G Satterlee
P G Tarassoff
1 January 1994